Skip to main content
. Author manuscript; available in PMC: 2023 Feb 11.
Published in final edited form as: N Engl J Med. 2022 Aug 11;387(6):506–513. doi: 10.1056/NEJMoa2204253

Table 2.

Primary Effectiveness Outcome (Relapse).

Measure Treatment (N = 38) Control (N = 35)
number of patients (percent)
Surgery 2 (5) 9 (26)

Emergency department visit 2 (5) 10 (29)

Total surgeries, emergency department visits, or both 4 (11) 15 (43)

Growth of secondary stones or fragments* 3 (8) 13 (37)

Total surgeries, emergency department visits, or growth of stones 6 (16) 22 (63)
*

Seven patients in the treatment group had residual fragments after ureteros-copy. Of the 13 patients in the control group who did not have a relapse, 2 were free of kidney stones after ureteroscopy.